Clinical Trial: Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Influenza Immunization
Study Type: INTERVENTIONAL
Official Title: Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adults Aged 18 Years and Older
Brief Summary:
The purpose of this study is to evaluate the safety and immunogenicity of a single intramuscular (IM) injection of up to 3 dose levels of Quadrivalent Influenza mRNA Vaccine MRT5410 compared to an active control (QIV SD, QIV HD [adults ? 65 years of age only], or RIV4) in adults 18 years of age and older.
Read more